Key facts
- This page summarizes Joseph H. Crabb's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2022, 16:00.
Joseph H. Crabb - 09 Mar 2022 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)
- Reporting relationship
- Former VP and CSO
- Issuer ticker
- ICCC
- Reported as of
- 09 Mar 2022
- Net transaction value
- +$5,840
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2022, 16:00:29 UTC
- Prior SEC filing
- 18 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Michael F Brigham Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph H. Crabb filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 14 Mar 2022.
Change
- Previous filing in this sequence was filed on 18 May 2022.
- Current net transaction value: +$5,840.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICCC
transaction
Common Stock, par value $0.10 per share
Disposed to Issuer
- Transaction value
- $5,840
- Shares
- +1,000
- Change %
- +0.7%
- Price
- $5.84
- Shares after
- 142,845
- Date
- 09 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.